Real-world outcomes of patients with metastatic castration-resistant prostate cancer (mCRPC) and tumors harboring androgen receptor (AR) ligand-binding domain (LBD) mutations.
| Autor: | Stewart, Tyler F., Chandiwana, David, Doyle, Ashley, Boame, Nana, Saha, Jayati, Zhang, Nicole, Benjumea, Darrin, Rava, Andrew, Parameswaran, Janaki, Edwards, Michelle L., Lang, Joshua Michael |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p77-77, 235p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|